Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
62
URGN Quote, Financials, Valuation and Earnings
Last price:
$15.24
Seasonality move
:
0.45%
Day range:
$14.33 - $15.50
52-week range:
$3.42 - $17.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.78x
P/B ratio:
16.41x
Volume:
2M
Avg. volume:
4.1M
1-year change:
-8.76%
Market cap:
$710.5M
Revenue:
$90.4M
EPS (TTM):
-$3.18
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.8M | $48M | $64.4M | $82.7M | $90.4M | |
| Revenue Growth (YoY) | 65450% | 307.17% | 33.96% | 28.52% | 9.29% | |
| Cost of Revenues | $1M | $5.2M | $7.7M | $9.4M | $8.9M | |
| Gross Profit | $10.8M | $42.9M | $56.7M | $73.4M | $81.5M | |
| Gross Profit Margin | 91.45% | 89.27% | 88.11% | 88.68% | 90.18% | |
| R&D Expenses | $47.3M | $47.6M | $52.9M | $45.6M | $57.1M | |
| Selling, General & Admin | $90.2M | $87.5M | $82.8M | $93.3M | $121.2M | |
| Other Inc / (Exp) | -- | -$17.3M | -$21.5M | -$20.7M | -$23.6M | |
| Operating Expenses | $137.5M | $135.2M | $135.7M | $138.9M | $178.3M | |
| Operating Income | -$126.7M | -$92.3M | -$79M | -$65.5M | -$96.8M | |
| Net Interest Expenses | -- | -- | $7.5M | $12.1M | $3.6M | |
| EBT. Incl. Unusual Items | -$125.1M | -$109.4M | -$108M | -$98.3M | -$124M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.4M | $1.4M | $1.8M | $3.9M | $2.8M | |
| Net Income to Company | -$128.5M | -$110.8M | -$109.8M | -$102.2M | -$126.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$128.5M | -$110.8M | -$109.8M | -$102.2M | -$126.9M | |
| Basic EPS (Cont. Ops) | -$5.90 | -$4.96 | -$4.81 | -$3.55 | -$2.96 | |
| Diluted EPS (Cont. Ops) | -$5.90 | -$4.96 | -$4.81 | -$3.55 | -$2.96 | |
| Weighted Average Basic Share | $21.8M | $22.3M | $22.8M | $28.8M | $42.9M | |
| Weighted Average Diluted Share | $21.8M | $22.3M | $22.8M | $28.8M | $42.9M | |
| EBITDA | -$124.7M | -$107.6M | -$97.8M | -$81.9M | -$110.3M | |
| EBIT | -$126.7M | -$109.4M | -$99.6M | -$83.6M | -$111.5M | |
| Revenue (Reported) | $11.8M | $48M | $64.4M | $82.7M | $90.4M | |
| Operating Income (Reported) | -$126.7M | -$92.3M | -$79M | -$65.5M | -$96.8M | |
| Operating Income (Adjusted) | -$126.7M | -$109.4M | -$99.6M | -$83.6M | -$111.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.5M | $13.6M | $17.2M | $18.8M | $20.3M | |
| Revenue Growth (YoY) | -- | 81.22% | 26.75% | 9.24% | 7.84% | |
| Cost of Revenues | $897K | $1.5M | $2.3M | $1.7M | $2.3M | |
| Gross Profit | $6.6M | $12M | $14.9M | $17.1M | $17.9M | |
| Gross Profit Margin | 88.02% | 88.76% | 86.83% | 90.8% | 88.5% | |
| R&D Expenses | $10.5M | $12.7M | $12.5M | $15.5M | $19.9M | |
| Selling, General & Admin | $22.2M | $21.3M | $24.5M | $27.3M | $35M | |
| Other Inc / (Exp) | -- | -$5.8M | -$5.2M | -$5.8M | -$4.7M | |
| Operating Expenses | $32.7M | $34M | $37M | $42.8M | $54.8M | |
| Operating Income | -$26.1M | -$22M | -$22M | -$25.7M | -$36.9M | |
| Net Interest Expenses | -- | $280K | $2.9M | $649K | $1.9M | |
| EBT. Incl. Unusual Items | -$25.9M | -$28.1M | -$30.2M | -$32.2M | -$43.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $325K | $21K | $54K | $392K | |
| Net Income to Company | -$25.9M | -$28.4M | -$30.2M | -$32.3M | -$43.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$25.9M | -$28.4M | -$30.2M | -$32.3M | -$43.8M | |
| Basic EPS (Cont. Ops) | -$1.17 | -$1.25 | -$1.30 | -$0.87 | -$0.92 | |
| Diluted EPS (Cont. Ops) | -$1.17 | -$1.25 | -$1.30 | -$0.87 | -$0.92 | |
| Weighted Average Basic Share | $22.2M | $22.6M | $23.3M | $37.1M | $47.4M | |
| Weighted Average Diluted Share | $22.2M | $22.6M | $23.3M | $37.1M | $47.4M | |
| EBITDA | -$25.7M | -$27.3M | -$26.2M | -$29.4M | -$38.9M | |
| EBIT | -$26.1M | -$27.8M | -$26.6M | -$29.8M | -$39.4M | |
| Revenue (Reported) | $7.5M | $13.6M | $17.2M | $18.8M | $20.3M | |
| Operating Income (Reported) | -$26.1M | -$22M | -$22M | -$25.7M | -$36.9M | |
| Operating Income (Adjusted) | -$26.1M | -$27.8M | -$26.6M | -$29.8M | -$39.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $19.3M | $54.1M | $68M | $84.3M | $91.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.9M | $5.8M | $8.4M | $8.8M | $9.5M | |
| Gross Profit | $17.4M | $48.3M | $59.6M | $75.5M | $82.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $41.2M | $49.8M | $52.7M | $48.6M | $61.5M | |
| Selling, General & Admin | $90.4M | $86.6M | $86M | $96.1M | $128.8M | |
| Other Inc / (Exp) | -- | -$23M | -$21M | -$21.3M | -$22.7M | |
| Operating Expenses | $131.7M | $136.5M | $138.7M | $144.7M | $190.3M | |
| Operating Income | -$114.3M | -$88.1M | -$79.1M | -$69.2M | -$108M | |
| Net Interest Expenses | -- | $323K | $10M | $9.8M | $4.6M | |
| EBT. Incl. Unusual Items | -$113.3M | -$111.5M | -$110.2M | -$100.4M | -$135.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.4M | $1.8M | $1.5M | $4M | $3.2M | |
| Net Income to Company | -$116.6M | -$113.3M | -$111.6M | -$104.3M | -$138.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$116.6M | -$113.3M | -$111.6M | -$104.3M | -$138.4M | |
| Basic EPS (Cont. Ops) | -$5.30 | -$5.04 | -$4.83 | -$3.24 | -$3.18 | |
| Diluted EPS (Cont. Ops) | -$5.30 | -$5.04 | -$4.83 | -$3.24 | -$3.18 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$112.3M | -$109.4M | -$96.6M | -$85.1M | -$119.8M | |
| EBIT | -$114.3M | -$111.2M | -$98.4M | -$86.8M | -$121.1M | |
| Revenue (Reported) | $19.3M | $54.1M | $68M | $84.3M | $91.9M | |
| Operating Income (Reported) | -$114.3M | -$88.1M | -$79.1M | -$69.2M | -$108M | |
| Operating Income (Adjusted) | -$114.3M | -$111.2M | -$98.4M | -$86.8M | -$121.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.5M | $13.6M | $17.2M | $18.8M | $20.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $897K | $1.5M | $2.3M | $1.7M | $2.3M | |
| Gross Profit | $6.6M | $12M | $14.9M | $17.1M | $17.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.5M | $12.7M | $12.5M | $15.5M | $19.9M | |
| Selling, General & Admin | $22.2M | $21.3M | $24.5M | $27.3M | $35M | |
| Other Inc / (Exp) | -- | -$5.8M | -$5.2M | -$5.8M | -$4.7M | |
| Operating Expenses | $32.7M | $34M | $37M | $42.8M | $54.8M | |
| Operating Income | -$26.1M | -$22M | -$22M | -$25.7M | -$36.9M | |
| Net Interest Expenses | -- | $280K | $2.9M | $649K | $1.9M | |
| EBT. Incl. Unusual Items | -$25.9M | -$28.1M | -$30.2M | -$32.2M | -$43.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $325K | $21K | $54K | $392K | |
| Net Income to Company | -$25.9M | -$28.4M | -$30.2M | -$32.3M | -$43.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$25.9M | -$28.4M | -$30.2M | -$32.3M | -$43.8M | |
| Basic EPS (Cont. Ops) | -$1.17 | -$1.25 | -$1.30 | -$0.87 | -$0.92 | |
| Diluted EPS (Cont. Ops) | -$1.17 | -$1.25 | -$1.30 | -$0.87 | -$0.92 | |
| Weighted Average Basic Share | $22.2M | $22.6M | $23.3M | $37.1M | $47.4M | |
| Weighted Average Diluted Share | $22.2M | $22.6M | $23.3M | $37.1M | $47.4M | |
| EBITDA | -$25.7M | -$27.3M | -$26.2M | -$29.4M | -$38.9M | |
| EBIT | -$26.1M | -$27.8M | -$26.6M | -$29.8M | -$39.4M | |
| Revenue (Reported) | $7.5M | $13.6M | $17.2M | $18.8M | $20.3M | |
| Operating Income (Reported) | -$26.1M | -$22M | -$22M | -$25.7M | -$36.9M | |
| Operating Income (Adjusted) | -$26.1M | -$27.8M | -$26.6M | -$29.8M | -$39.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $52.9M | $44.4M | $55.4M | $95M | $172M | |
| Short Term Investments | $49.2M | $44.8M | $44.6M | $42M | $64.7M | |
| Accounts Receivable, Net | $7M | $11.7M | $12.7M | $15.4M | $20.3M | |
| Inventory | $2M | $4.8M | $4.3M | $5.7M | $9.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.4M | $7.5M | $11.1M | $10.3M | $8.8M | |
| Total Current Assets | $115.6M | $114.4M | $128.9M | $169.2M | $276.1M | |
| Property Plant And Equipment | $4.2M | $3.1M | $3.7M | $2.4M | $3.8M | |
| Long-Term Investments | $1.9M | $675K | -- | $4.5M | $5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $289K | $1.5M | $3M | $2.3M | $765K | |
| Total Assets | $122M | $119.7M | $135.6M | $178.3M | $285.7M | |
| Accounts Payable | $3.3M | $5.8M | $5.5M | $6.5M | $10.9M | |
| Accrued Expenses | $6.8M | $6.3M | $6.9M | $10M | $16.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.9M | $3.3M | $3.3M | $3.9M | $7.9M | |
| Total Current Liabilities | $21.4M | $22.4M | $23.9M | $31.2M | $45.9M | |
| Long-Term Debt | -- | -- | $97.5M | $98.6M | $121.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $25.7M | $111.3M | $225M | $243.5M | $294.5M | |
| Common Stock | $60K | $61K | $63K | $89K | $115K | |
| Other Common Equity Adj | $271K | -$25K | -$107K | $12K | $56K | |
| Common Equity | $96.4M | $8.4M | -$89.4M | -$65.2M | -$8.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $96.4M | $8.4M | -$89.4M | -$65.2M | -$8.8M | |
| Total Liabilities and Equity | $122M | $119.7M | $135.6M | $178.3M | $285.7M | |
| Cash and Short Terms | $102M | $89.1M | $100M | $137M | $236.7M | |
| Total Debt | -- | -- | $97.5M | $98.6M | $121.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $40.5M | $105.4M | $36.5M | $131.4M | $104M | |
| Short Term Investments | $35.4M | $31.1M | $28.5M | $32.6M | $91.9M | |
| Accounts Receivable, Net | $6.3M | $9.5M | $12.5M | $14.2M | $19.6M | |
| Inventory | $3.3M | $4.8M | $5.5M | $7.2M | $7.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $6.3M | $9.3M | $12.1M | $10.5M | $13M | |
| Total Current Assets | $93.1M | $160.5M | $96M | $196.8M | $237.2M | |
| Property Plant And Equipment | $4M | $2.7M | $3.4M | $2M | $5.4M | |
| Long-Term Investments | -- | $674K | $10.2M | $481K | $4.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $289K | $1.8M | $3.4M | $1.3M | $547K | |
| Total Assets | $97.4M | $165.7M | $113M | $200.6M | $247.6M | |
| Accounts Payable | $6.1M | $4.2M | $7M | $6.3M | $14.6M | |
| Accrued Expenses | $4.5M | $5.7M | $10.2M | $11.9M | $15.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.7M | $4M | $3.2M | $3.2M | $4.7M | |
| Total Current Liabilities | $17M | $19.1M | $25.2M | $26.3M | $42M | |
| Long-Term Debt | -- | $70.8M | $97.9M | $97.6M | $122.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $20.9M | $182.8M | $229.5M | $240.7M | $294.1M | |
| Common Stock | $61K | $62K | $64K | $99K | $126K | |
| Other Common Equity Adj | $143K | -$69K | -$45K | -$37K | $14K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $76.5M | -$17.1M | -$116.6M | -$40.1M | -$46.5M | |
| Total Liabilities and Equity | $97.4M | $165.7M | $113M | $200.6M | $247.6M | |
| Cash and Short Terms | $75.9M | $136.4M | $65.1M | $164M | $195.9M | |
| Total Debt | -- | $70.8M | $97.9M | $97.6M | $122.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$128.5M | -$110.8M | -$109.8M | -$102.2M | -$126.9M | |
| Depreciation & Amoritzation | $2M | $1.8M | $1.8M | $1.7M | $1.2M | |
| Stock-Based Compensation | $28M | $23.1M | $10.6M | $9.3M | $13.1M | |
| Change in Accounts Receivable | -$7M | -$4.7M | -$987K | -$2.7M | -$4.9M | |
| Change in Inventories | -$2M | -$2.9M | -$362K | -$1.3M | -$3.6M | |
| Cash From Operations | -$105.9M | -$84.9M | -$87.6M | -$76.4M | -$96.8M | |
| Capital Expenditures | $1.2M | $752K | $254K | $194K | $295K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $93.2M | $4.1M | $1.1M | -$953K | -$20.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $95.8M | -- | $24.5M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$66K | $72.3M | -$160K | -- | -- | |
| Cash From Financing | $16.5M | $72.3M | $97.1M | $116.9M | $194.6M | |
| Beginning Cash (CF) | $50.2M | $54.1M | $45.6M | $56.2M | $95.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.9M | -$8.5M | $10.6M | $39.6M | $77.2M | |
| Ending Cash (CF) | $54.1M | $45.6M | $56.2M | $95.8M | $173.1M | |
| Levered Free Cash Flow | -$107.1M | -$85.6M | -$87.8M | -$76.6M | -$97.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$25.9M | -$28.4M | -$30.2M | -$32.3M | -$43.8M | |
| Depreciation & Amoritzation | $428K | $456K | $435K | $351K | $497K | |
| Stock-Based Compensation | $6.2M | $2.9M | $2.3M | $2.8M | $3.1M | |
| Change in Accounts Receivable | $746K | $2.2M | $211K | $1.3M | $664K | |
| Change in Inventories | -$1.4M | $76K | -$1.1M | -$1.6M | $1.6M | |
| Cash From Operations | -$27.4M | -$24M | -$25.8M | -$31.7M | -$42M | |
| Capital Expenditures | $287K | $25K | $23K | -- | $44K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $15M | $13.6M | $6.3M | $13.5M | -$26M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $70.8M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$89K | -- | -- | -- | |
| Cash From Financing | $4K | $70.7M | $671K | $54.7M | $34K | |
| Beginning Cash (CF) | $54.1M | $45.6M | $56.2M | $95.8M | $173.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$12.4M | $60.3M | -$18.9M | $36.4M | -$68M | |
| Ending Cash (CF) | $41.7M | $105.9M | $37.4M | $132.3M | $105.1M | |
| Levered Free Cash Flow | -$27.7M | -$24M | -$25.8M | -$31.7M | -$42.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$116.6M | -$113.3M | -$111.6M | -$104.3M | -$138.4M | |
| Depreciation & Amoritzation | $2M | $1.8M | $1.8M | $1.6M | $1.3M | |
| Stock-Based Compensation | $26.6M | $19.9M | $9.9M | $9.8M | $13.4M | |
| Change in Accounts Receivable | -$6.3M | -$3.2M | -$3M | -$1.7M | -$5.5M | |
| Change in Inventories | -$3.3M | -$1.4M | -$1.6M | -$1.8M | -$347K | |
| Cash From Operations | -$97.7M | -$81.5M | -$89.4M | -$82.3M | -$107.1M | |
| Capital Expenditures | $1.4M | $490K | $252K | $171K | $339K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $95.2M | $2.6M | -$6.3M | $6.3M | -$60.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $70.8M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $72.2M | -- | -- | -- | |
| Cash From Financing | $16.4M | $143.1M | $27.1M | $170.9M | $140M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $14M | $64.2M | -$68.6M | $94.9M | -$27.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$99.1M | -$82M | -$89.6M | -$82.5M | -$107.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$25.9M | -$28.4M | -$30.2M | -$32.3M | -$43.8M | |
| Depreciation & Amoritzation | $428K | $456K | $435K | $351K | $497K | |
| Stock-Based Compensation | $6.2M | $2.9M | $2.3M | $2.8M | $3.1M | |
| Change in Accounts Receivable | $746K | $2.2M | $211K | $1.3M | $664K | |
| Change in Inventories | -$1.4M | $76K | -$1.1M | -$1.6M | $1.6M | |
| Cash From Operations | -$27.4M | -$24M | -$25.8M | -$31.7M | -$42M | |
| Capital Expenditures | $287K | $25K | $23K | -- | $44K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $15M | $13.6M | $6.3M | $13.5M | -$26M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $70.8M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$89K | -- | -- | -- | |
| Cash From Financing | $4K | $70.7M | $671K | $54.7M | $34K | |
| Beginning Cash (CF) | $54.1M | $45.6M | $56.2M | $95.8M | $173.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$12.4M | $60.3M | -$18.9M | $36.4M | -$68M | |
| Ending Cash (CF) | $41.7M | $105.9M | $37.4M | $132.3M | $105.1M | |
| Levered Free Cash Flow | -$27.7M | -$24M | -$25.8M | -$31.7M | -$42.1M | |
Get URGN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
URGN
Sector
P/E ratio
--
24.07x
PEG ratio
--
0.00x
P/B ratio
16.41x
1.81x
Price / LTM sales
7.78x
1.67x
Growth Metrics
URGN
Sector
Revenue growth
7.84%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
449.77%
8.01%
Earnings forecast
-$0.83
-$0.20
Profitability
URGN
Sector
Profitability FY 2024
$81.5M
$47.5M
Return on invested capital
-132.75%
-16.26%
Return on assets
-52.53%
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
12
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
11
Balance Sheet
URGN
Sector
Total cash
$195.9M
$35.7M
Short term investments
$64.7M
$29.7M
Total assets
$285.7M
$106.9M
Long term debt
$122.1M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.92% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.03% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 9.69% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
